MSB 4.07% $1.15 mesoblast limited

Elli Lilly and now Regeneron not treating advanced COIVD-19 sufferers, page-6

  1. 5,078 Posts.
    lightbulb Created with Sketch. 570
    great links, and why doesn't this hit the main media in Australia?
    the power of big phramas. when i read reports it made no sense at all why this drug had such powerful cover. The $billion for the gilead deal has a lot of idiocy of Government that panic, ego wanting to look good in seeing to be doing something....like the Australian Gov, seeming suppporting gilead unworthy product just becuase its american and backed by the trumpist.
    At least some quality in this links calling these idiots out. I like to be able to blow a billion on a wasted decision just because i can, (perfer to put that into MSB and others more interested in helping people)

    “This is a very, very bad look for the FDA, and the dealings between Gilead and EU make it another layer of badness,” says Eric Topol, a cardiologist at the Scripps Research Translational Institute who objected to remdesivir’s FDA approval."

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.15
Change
0.045(4.07%)
Mkt cap ! $1.313B
Open High Low Value Volume
$1.08 $1.16 $1.08 $4.681M 4.170M

Buyers (Bids)

No. Vol. Price($)
1 99680 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 31000 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.